A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease

Clinical trial NCT05842967 · COMPLETED

Trial details

NCT number: NCT05842967
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

RESPIRATORY SYNCYTIAL VIRUS (RSV)

Start date: 2023-05-11
Primary completion: 2024-03-18
Enrollment: 885

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.